• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

木樨草素调节信号通路发挥抗癌作用的进展、药代动力学及未来展望:综述。

Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects: A review.

机构信息

Department of Thoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng, PR China.

Medical School of Nantong University, Nantong, PR China.

出版信息

Medicine (Baltimore). 2024 Aug 23;103(34):e39398. doi: 10.1097/MD.0000000000039398.

DOI:10.1097/MD.0000000000039398
PMID:39183411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11346905/
Abstract

Luteolin (3, 4, 5, 7-tetrahydroxyflavone) are natural flavonoids widely found in vegetables, fruits and herbs, with anti-tumor, anti-inflammatory and antioxidant effects, and also play an anti-cancer effect in various cancers such as lung, breast, prostate, and liver cancer, etc. Specifically, the anti-cancer mechanism includes regulation of various signaling pathways to induce apoptosis of tumor cells, inhibition of tumor cell proliferation and metastasis, anti-angiogenesis, regulation of immune function, synergistic anti-cancer drugs and regulation of reactive oxygen species levels of tumor cells. Specific anti-cancer mechanisms include regulation of various signaling pathways to induce apoptosis, inhibition of tumor cell proliferation and metastasis, anti-angiogenesis, reversal of epithelial-mesenchymal transition, regulation of immune function, synergism with anti-cancer drugs and regulation of reactive oxygen species levels in tumor cells. This paper integrates the latest cutting-edge research on luteolin and combines it with the prospect of future clinical applications, aiming to explore the mechanism of luteolin exerting different anticancer effects through the regulation of different signaling pathways, so as to provide a practical theoretical basis for the use of luteolin in clinical treatment and hopefully provide some reference for the future research direction of luteolin.

摘要

木樨草素(3,4,5,7-四羟基黄酮)是广泛存在于蔬菜、水果和草药中的天然类黄酮,具有抗肿瘤、抗炎和抗氧化作用,对肺癌、乳腺癌、前列腺癌和肝癌等多种癌症也具有抗癌作用。具体而言,其抗癌机制包括调节各种信号通路诱导肿瘤细胞凋亡、抑制肿瘤细胞增殖和转移、抗血管生成、调节免疫功能、与抗癌药物协同作用以及调节肿瘤细胞内活性氧水平。具体的抗癌机制包括调节各种信号通路诱导凋亡、抑制肿瘤细胞增殖和转移、抗血管生成、上皮间质转化的逆转、调节免疫功能、与抗癌药物协同作用以及调节肿瘤细胞内活性氧水平。本文整合了木樨草素的最新前沿研究,并结合未来临床应用的前景,旨在探讨木樨草素通过调节不同信号通路发挥不同抗癌作用的机制,为木樨草素在临床治疗中的应用提供实用的理论基础,并有望为木樨草素的未来研究方向提供一些参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11346905/1a494109de21/medi-103-e39398-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11346905/8500be43fc21/medi-103-e39398-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11346905/404af980a5ea/medi-103-e39398-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11346905/1a494109de21/medi-103-e39398-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11346905/8500be43fc21/medi-103-e39398-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11346905/404af980a5ea/medi-103-e39398-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cccf/11346905/1a494109de21/medi-103-e39398-g003.jpg

相似文献

1
Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects: A review.木樨草素调节信号通路发挥抗癌作用的进展、药代动力学及未来展望:综述。
Medicine (Baltimore). 2024 Aug 23;103(34):e39398. doi: 10.1097/MD.0000000000039398.
2
Luteolin, a flavonoid with potential for cancer prevention and therapy.木犀草素,一种具有癌症预防和治疗潜力的黄酮类化合物。
Curr Cancer Drug Targets. 2008 Nov;8(7):634-46. doi: 10.2174/156800908786241050.
3
Luteolin, a flavonoid, as an anticancer agent: A review.木樨草素,一种类黄酮,作为一种抗癌剂:综述。
Biomed Pharmacother. 2019 Apr;112:108612. doi: 10.1016/j.biopha.2019.108612. Epub 2019 Feb 21.
4
Luteolin: A promising modulator of apoptosis and survival signaling in liver cancer.木樨草素:肝癌细胞凋亡和存活信号的有前途的调节剂。
Pathol Res Pract. 2024 Aug;260:155430. doi: 10.1016/j.prp.2024.155430. Epub 2024 Jul 1.
5
Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis.木樨草素在癌症转移中的多方面作用:EMT、血管生成、细胞外基质降解和细胞凋亡。
Int J Mol Sci. 2023 May 16;24(10):8824. doi: 10.3390/ijms24108824.
6
Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways.木樨草素介导的不同癌症中的蛋白质网络和 microRNAs 靶向:聚焦 JAK-STAT、NOTCH、mTOR 和 TRAIL 介导的信号通路。
Pharmacol Res. 2020 Oct;160:105188. doi: 10.1016/j.phrs.2020.105188. Epub 2020 Sep 9.
7
Luteolin induces myelodysplastic syndrome‑derived cell apoptosis via the p53‑dependent mitochondrial signaling pathway mediated by reactive oxygen species.木犀草素通过活性氧介导的 p53 依赖性线粒体信号通路诱导骨髓增生异常综合征衍生细胞凋亡。
Int J Mol Med. 2018 Aug;42(2):1106-1115. doi: 10.3892/ijmm.2018.3696. Epub 2018 May 18.
8
Effects of luteolin on canine osteosarcoma: Suppression of cell proliferation and synergy with cisplatin.木樨草素对犬骨肉瘤的影响:抑制细胞增殖并与顺铂协同作用。
J Cell Physiol. 2019 Jun;234(6):9504-9514. doi: 10.1002/jcp.27638. Epub 2018 Oct 26.
9
Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.木樨草素和水飞蓟宾在神经胶质瘤细胞中的抗肿瘤活性:miR-7-1-3p 的过表达增强了木樨草素和水飞蓟宾抑制神经胶质瘤细胞自噬和诱导细胞凋亡的作用。
Apoptosis. 2016 Mar;21(3):312-28. doi: 10.1007/s10495-015-1198-x.
10
Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanisms.木樨草素在不影响药物转运蛋白功能的情况下诱导多药耐药癌细胞凋亡:涉及细胞系特异性凋亡机制。
Int J Cancer. 2012 Jun 1;130(11):2703-14. doi: 10.1002/ijc.26308. Epub 2011 Aug 25.

引用本文的文献

1
Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies.木犀草素的抗氧化和抗癌潜力:针对多种人类恶性肿瘤的综合方法
Food Sci Nutr. 2025 Jan 19;13(1):e4682. doi: 10.1002/fsn3.4682. eCollection 2025 Jan.